Chromosome Abnormalities in Patients Treated with Chlorpromazine, Perphenazine, and Lysergide

39Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

In a chromosome study on leucocyte cultures made in 13 patients treated with chlorpromazine, 15 treated with perphenazine, and nine treated with lysergide, a significantly higher frequency of gaps, breaks, and hypodiploid cells in the patients treated with perphenazine and lysergide occurred compared with the 41 controls studied. It is concluded that if some drugs can induce major chromosome abnormalities, and less toxic alternatives are available, the latter should be used in preference. © 1969, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Nielsen, J., Friedrich, U., & Tsuboi, T. (1969). Chromosome Abnormalities in Patients Treated with Chlorpromazine, Perphenazine, and Lysergide. British Medical Journal, 3(5671), 634–636. https://doi.org/10.1136/bmj.3.5671.634

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free